Clinical Trials Browser

Terminated × Has results × Neoplasms, Squamous Cell × Clear all

Adenocarcinoma, Breast Neoplasms, Carcinoma, Renal Cell, Camurati-Engelmann Syndrome, Liver Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Neoplasms, Squamous Cell

NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plus™ Pap

Terminated

5,859 enrolled 4 charts

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

NCT02837042 2022-06-21

Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma

Phase 2 Terminated

6 enrolled 10 charts

Genitourinary

Penile Neoplasms, Neoplasms, Squamous Cell

NCT03937791 2021-04-13

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Phase 2 Terminated

1 enrolled 8 charts

Neoplasms, Squamous Cell, Papillomavirus Infections

NCT01111058 2020-04-07

Everolimus Versus Placebo in Head and Neck Cancer

Phase 2 Terminated

52 enrolled 13 charts

Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT00591149 2017-06-14

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

Phase 2 Terminated

16 enrolled 5 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Neoplasms, Squamous Cell

Clinical Trials

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Intended Use Study of the BD SurePath Plus™ Pap

Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Everolimus Versus Placebo in Head and Neck Cancer

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer